Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town

Background: Mycobacterium tuberculosis (MTB) and Human Immunodeficiency Virus (HIV) remain a major public health concern in South Africa (SA) with high mortality rates in patients with MTB and HIV co-infection. In 2016 Urinary Lipoarabinomannan (ULAM) became available in SA to expedite the diagnosis...

Full description

Saved in:
Bibliographic Details
Main Author: Erwee, Christie
Other Authors: Dlamini, Sipho
Format: Thesis
Language:English
English
Published: Department of Medicine 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614361306005504
access_status_str Open Access
author Erwee, Christie
author2 Dlamini, Sipho
author_browse Dlamini, Sipho
Erwee, Christie
author_facet Dlamini, Sipho
Erwee, Christie
author_sort Erwee, Christie
collection Thesis
description Background: Mycobacterium tuberculosis (MTB) and Human Immunodeficiency Virus (HIV) remain a major public health concern in South Africa (SA) with high mortality rates in patients with MTB and HIV co-infection. In 2016 Urinary Lipoarabinomannan (ULAM) became available in SA to expedite the diagnosis and treatment of Tuberculosis (TB) in this vulnerable population. Objectives To describe the experience at a district level hospital following the availability of ULAM testing for investigating HIV positive TB suspects. Firstly, to define the population and clinical outcomes in this cohort and secondly to assess if the hospital's standard operating procedure (SOP) regarding ULAM testing was followed and what additional MTB investigations were performed. Methods An observational, retrospective cohort study of patients who underwent ULAM testing at Mitchells Plain District Hospital (MPDH) was conducted from 2016 until 2018. The following data was collected: age, gender, CD4 count, viral load (VL), whether Antiretroviral Treatment (ART) naïve or interrupted and duration of ART if on treatment. Additionally, MTB diagnostic tests were performed and finally, patient clinical outcomes with regards to length of stay (LOS) and 30-day mortality and whether TB treatment was initiated. Descriptive statistics were used to analyse the data. Results 324 participants were included in the study. 54.6% of participants were female and the median age of the entire cohort was 36 (IQR 30-34). Median CD4 count was 41 (IQR 16-76) with high viral load of log 4.9 (IQR 3.9-5.4). 44.1% of participants were ART naïve, 36.1% of participants were on treatment and 19.8% had interrupted treatment. The median duration of ART was 0.6 years (IQR 0.1-2). 750 MTB specific tests were performed in the cohort, 48% of the participants initiated on TB treatment had positive microbiological results proving MTB infection. Overall 30-day mortality was 12.7%. Conclusions This study showed participants who were severely immunocompromised with little ART exposure and a mortality rate of 12.7%. Patients were frequently initiated on empiric MTB treatment with a proportion of participants not being adequately investigated, particularly in the LAM negative group. Sputum was the most frequent MTB specific test performed. Clinicians adhered to the SOP put in place to guide the use of ULAM.
format Thesis
id oai:open.uct.ac.za:11427/41605
institution University of Cape Town (South Africa)
language English
eng
last_indexed 2026-06-10T12:50:49.328Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher Department of Medicine
publisherStr Department of Medicine
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/41605 Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town Erwee, Christie Dlamini, Sipho urinary lipoarabinomannan ULAM disseminated tuberculosis TB Background: Mycobacterium tuberculosis (MTB) and Human Immunodeficiency Virus (HIV) remain a major public health concern in South Africa (SA) with high mortality rates in patients with MTB and HIV co-infection. In 2016 Urinary Lipoarabinomannan (ULAM) became available in SA to expedite the diagnosis and treatment of Tuberculosis (TB) in this vulnerable population. Objectives To describe the experience at a district level hospital following the availability of ULAM testing for investigating HIV positive TB suspects. Firstly, to define the population and clinical outcomes in this cohort and secondly to assess if the hospital's standard operating procedure (SOP) regarding ULAM testing was followed and what additional MTB investigations were performed. Methods An observational, retrospective cohort study of patients who underwent ULAM testing at Mitchells Plain District Hospital (MPDH) was conducted from 2016 until 2018. The following data was collected: age, gender, CD4 count, viral load (VL), whether Antiretroviral Treatment (ART) naïve or interrupted and duration of ART if on treatment. Additionally, MTB diagnostic tests were performed and finally, patient clinical outcomes with regards to length of stay (LOS) and 30-day mortality and whether TB treatment was initiated. Descriptive statistics were used to analyse the data. Results 324 participants were included in the study. 54.6% of participants were female and the median age of the entire cohort was 36 (IQR 30-34). Median CD4 count was 41 (IQR 16-76) with high viral load of log 4.9 (IQR 3.9-5.4). 44.1% of participants were ART naïve, 36.1% of participants were on treatment and 19.8% had interrupted treatment. The median duration of ART was 0.6 years (IQR 0.1-2). 750 MTB specific tests were performed in the cohort, 48% of the participants initiated on TB treatment had positive microbiological results proving MTB infection. Overall 30-day mortality was 12.7%. Conclusions This study showed participants who were severely immunocompromised with little ART exposure and a mortality rate of 12.7%. Patients were frequently initiated on empiric MTB treatment with a proportion of participants not being adequately investigated, particularly in the LAM negative group. Sputum was the most frequent MTB specific test performed. Clinicians adhered to the SOP put in place to guide the use of ULAM. 2025-08-18T11:07:13Z 2025-08-18T11:07:13Z 2025 2025-07-08T06:57:42Z Thesis / Dissertation Masters MMed http://hdl.handle.net/11427/41605 en eng application/pdf Department of Medicine Faculty of Health Sciences University of Cape Town
spellingShingle urinary lipoarabinomannan
ULAM
disseminated tuberculosis
TB
Erwee, Christie
Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town
thesis_degree_str Master's
title Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town
title_full Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town
title_fullStr Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town
title_full_unstemmed Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town
title_short Retrospective review of urinary lipoarabinomannan (ULAM) in the diagnosis of disseminated tuberculosis (TB) in medical inpatients at a district level hospital in Cape Town
title_sort retrospective review of urinary lipoarabinomannan ulam in the diagnosis of disseminated tuberculosis tb in medical inpatients at a district level hospital in cape town
topic urinary lipoarabinomannan
ULAM
disseminated tuberculosis
TB
url http://hdl.handle.net/11427/41605
work_keys_str_mv AT erweechristie retrospectivereviewofurinarylipoarabinomannanulaminthediagnosisofdisseminatedtuberculosistbinmedicalinpatientsatadistrictlevelhospitalincapetown